Professor Cyndi Shannon Weickert and her team at the Schizophrenia Research Laboratory* are conducting the Institute’s first clinical drug trial aimed at improving cognitive performance in people with schizophrenia.

The Australian Schizophrenia Research Bank has played a key role in a global study that investigated genetic variants associated with schizophrenia. The study replicated findings from previous genetic research and made new discoveries.

This year you can jump the queues at the City2Surf and start at the front of the pack as a Gold Charity participant for the Schizophrenia Research Institute.